glp 1 agonists in development Glucagon-like peptide-1 receptor: mechanisms and advances therapy Glucagon-like peptide-1 receptor: mechanisms and

The primary outcome was the new onset of adverse CVEs, including heart failure, composite incidence of major adverse cardiovascular events (MACE

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data

This combination leverages amylin's ability to promote feelings of fullness and slow stomach emptying

Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work